Ocugen, Inc.

General ticker "OCGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $290.1M (TTM average)

Ocugen, Inc. does not follow the US Stock Market performance with the rate: -12.6%.

Estimated limits based on current volatility of 5.0%: low 0.66$, high 0.73$

Factors to consider:

  • Earnings expected soon, date: 2025-05-13 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.39$, 1.93$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.32$, 1.53$]

Financial Metrics affecting the OCGN estimates:

  • Negative: Non-GAAP EPS, $ of -0.18 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -15.41 <= 1.79
  • Positive: 22.52 < Shareholder equity ratio, % of 35.94 <= 43.26
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term OCGN quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-090.60.650.70.750.8
Price $

Long-term OCGN plot with estimates

0.40.60.811.21.41.61.82Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.06−0.04−0.020
OCGNS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $2.49MM $6.04MM $4.05MM
Operating Expenses $91.56MM $71.57MM $58.81MM
Operating Income $-89.07MM $-65.53MM $-54.76MM
Non-Operating Income $2.27MM $2.45MM $0.70MM
R&D Expense $56.16MM $39.57MM $32.13MM
Income(Loss) $-86.80MM $-63.08MM $-54.05MM
Profit(Loss)* $-86.80MM $-63.08MM $-54.05MM
Stockholders Equity $73.98MM $40.56MM $29.63MM
Assets $108.63MM $64.55MM $82.44MM
Operating Cash Flow $-60.08MM $-62.05MM $-42.14MM
Capital expenditure $4.46MM $10.48MM $3.38MM
Investing Cash Flow $-16.97MM $3.08MM $-3.38MM
Financing Cash Flow $59.48MM $20.88MM $64.86MM
Earnings Per Share** $-0.40 $-0.26 $-0.20

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.